Genufood Energy Enzymes Corp. (GFOO)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Genufood Energy Enzymes Corp. (GFOO) with AI Score 44/100 (Weak). Genufood Energy Enzymes Corp. is a shell company formerly involved in manufacturing and distributing enzyme products. Currently, the company does not have significant operations. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 17, 2026Genufood Energy Enzymes Corp. (GFOO) Financial Services Profile
Genufood Energy Enzymes Corp., operating within the Financial Services sector as a shell company, lacks significant current operations after previously engaging in the manufacturing and distribution of enzyme products. The company's minimal market capitalization and high beta reflect its speculative nature and limited activity in the market.
Investment Thesis
Investing in Genufood Energy Enzymes Corp. (GFOO) presents a highly speculative opportunity. The company's current lack of significant operations and minimal market capitalization of $0.00B indicate substantial risk. The high beta of 5.09 suggests extreme volatility relative to the market. Potential value drivers hinge on the possibility of a reverse merger, acquisition, or strategic shift into a new business. However, without concrete plans or active operations, the investment thesis relies heavily on speculation. Investors should carefully consider the risks associated with shell companies and the lack of financial performance data.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates the company's small size and limited investor confidence.
- A P/E ratio of -0.13 reflects negative earnings and the company's lack of profitability.
- Beta of 5.09 suggests high volatility compared to the overall market.
- Dividend yield of None indicates that the company does not currently distribute profits to shareholders.
- The company's status as a shell company implies a high degree of uncertainty and risk.
Competitors & Peers
Strengths
- Existing corporate structure
- Publicly listed status
- Potential for reverse merger
- Low market capitalization
Weaknesses
- Lack of active operations
- Minimal assets
- Negative earnings
- High beta
Catalysts
- Upcoming: Potential announcement of a reverse merger agreement.
- Upcoming: Possible acquisition offer from another company.
- Upcoming: Strategic pivot into a new business sector.
- Ongoing: Exploration of potential business opportunities.
- Ongoing: Efforts to raise capital for future ventures.
Risks
- Potential: Failure to find a suitable merger or acquisition target.
- Potential: Inability to raise capital to fund new ventures.
- Ongoing: Limited liquidity and trading volume.
- Ongoing: High volatility and speculative nature of the stock.
- Potential: Delisting from the OTC market.
Growth Opportunities
- Reverse Merger: A potential growth opportunity lies in a reverse merger, where a private company merges with GFOO to gain a public listing without undergoing the traditional IPO process. This could inject new assets, operations, and management into GFOO, revitalizing the company and potentially increasing its market value. The timeline for such a transaction is highly uncertain, dependent on finding a suitable private company and negotiating favorable terms. Market size is dependent on the valuation of the acquired company.
- Acquisition Target: GFOO could become an acquisition target for another company seeking a publicly traded shell. This would provide existing shareholders with a return on their investment, although the terms of the acquisition would determine the ultimate value. The timeline for an acquisition is unpredictable, influenced by market conditions and the strategic interests of potential acquirers. The market size is dependent on the acquisition price.
- Strategic Pivot: GFOO could strategically pivot into a new business sector, leveraging its existing corporate structure and public listing. This would require a significant investment of capital and resources, as well as a comprehensive business plan. The timeline for a strategic pivot is dependent on the company's ability to identify and execute a viable business strategy. Market size is dependent on the chosen sector.
- Capital Raise: GFOO could attempt to raise capital through equity or debt offerings to fund new ventures or acquisitions. This would require a compelling business plan and investor confidence in the company's management team. The timeline for a capital raise is dependent on market conditions and investor appetite. Market size is dependent on the amount of capital raised.
- Asset Acquisition: GFOO could acquire assets from other companies, such as intellectual property, equipment, or real estate. This would provide the company with tangible assets and potential revenue streams. The timeline for an asset acquisition is dependent on finding suitable assets and negotiating favorable terms. Market size is dependent on the value of the acquired assets.
Opportunities
- Reverse merger with a private company
- Acquisition by another company
- Strategic pivot into a new business
- Capital raise to fund new ventures
Threats
- Failure to find a suitable merger or acquisition target
- Inability to raise capital
- Economic downturn
- Increased regulatory scrutiny
Competitive Advantages
- As a shell company, GFOO's primary advantage is its existing corporate structure and public listing.
- This can provide a faster and less expensive route to market for private companies seeking to go public.
- However, GFOO lacks a traditional economic moat due to its lack of active operations.
About GFOO
Genufood Energy Enzymes Corp. was incorporated in 2010 and is based in Arcadia, California. The company's historical business involved the manufacturing, exporting, and distributing of enzyme products intended as supplements for both human and animal consumption. However, as of 2026, Genufood Energy Enzymes Corp. does not have significant ongoing operations. This transition from an active enzyme product business to a shell company represents a significant shift in the company's trajectory. The company's current state suggests a potential restructuring, acquisition target, or strategic pivot, although no specific plans have been publicly disclosed. The lack of current operations and minimal market capitalization reflect the speculative nature of the company's stock. The company's future direction remains uncertain, contingent on potential new ventures or strategic realignments.
What They Do
- Currently, Genufood Energy Enzymes Corp. does not have significant operations.
- Previously, the company manufactured enzyme products.
- The company exported enzyme products.
- They distributed enzyme products.
- The enzyme products were intended as supplements for human consumption.
- The enzyme products were also intended as supplements for animal consumption.
Business Model
- Historically, the company generated revenue through the sale of enzyme products.
- The company's business model involved manufacturing, exporting, and distributing these products.
- Currently, the company does not have an active business model.
Industry Context
Genufood Energy Enzymes Corp. operates within the shell company industry, a segment of the financial services sector characterized by companies with no active business operations or significant assets. These companies are often formed for the purpose of facilitating mergers, acquisitions, or reverse takeovers. The shell company industry is highly speculative, with potential for high returns but also significant risks. The competitive landscape is diverse, ranging from newly formed entities to established companies seeking to restructure or enter new markets. Genufood Energy Enzymes Corp.'s position as a shell company reflects its current lack of operational activity and dependence on future strategic developments.
Key Customers
- Historically, the company's customers included individuals seeking enzyme supplements.
- The company also served customers in the animal feed industry.
- Currently, the company does not have active customers.
Financials
Chart & Info
Genufood Energy Enzymes Corp. (GFOO) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Jan 29, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GFOO.
Price Targets
Wall Street price target analysis for GFOO.
MoonshotScore
What does this score mean?
The MoonshotScore rates GFOO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: David Tang
Unknown
David Tang is the managing member of Genufood Energy Enzymes Corp. Details regarding his prior experience and educational background are not available. His role involves overseeing the limited operations of the company, which currently functions as a shell corporation. The company employs only one individual, indicating a very lean operational structure.
Track Record: Given the company's current state as a shell corporation without significant operations, it is difficult to assess David Tang's track record in terms of driving revenue growth or achieving strategic milestones. His primary responsibility appears to be maintaining the company's corporate structure and exploring potential future opportunities.
GFOO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available, and may not be current in their reporting obligations. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, manipulation, and lack of transparency. These securities are often considered highly speculative.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure
- High potential for fraud or manipulation
- Lack of liquidity
- Speculative nature of the company
- Potential for delisting or suspension of trading
- Verify the company's registration and legal status
- Review any available financial statements
- Assess the company's management team and their experience
- Research the company's history and any past legal issues
- Understand the risks associated with investing in OTC Other stocks
- Monitor trading volume and bid-ask spreads
- Consult with a financial advisor
- Verify the company's registration with the SEC or other regulatory bodies.
- Check for any history of regulatory violations or legal issues.
- Assess the experience and qualifications of the company's management team.
- Look for any independent audits or certifications.
- Monitor news and press releases for any red flags.
What Investors Ask About Genufood Energy Enzymes Corp. (GFOO)
What does Genufood Energy Enzymes Corp. do?
Genufood Energy Enzymes Corp. currently operates as a shell company, lacking significant ongoing business operations. Historically, the company was involved in the manufacturing, exporting, and distributing of enzyme products intended for use as supplements in both human and animal diets. However, the company has since ceased these operations and is now seeking new strategic opportunities, such as a reverse merger, acquisition, or a pivot into a different business sector. Investors should note the speculative nature of the company's stock due to its lack of current revenue-generating activities.
What do analysts say about GFOO stock?
Given Genufood Energy Enzymes Corp.'s status as a shell company with no significant operations, there is limited to no analyst coverage available. The stock's valuation is primarily driven by speculation regarding potential future events, such as a reverse merger or acquisition. Key metrics like P/E ratio (-0.13) are not meaningful in the current context. Investors should conduct their own thorough due diligence and carefully consider the risks associated with investing in shell companies before making any investment decisions. The high beta of 5.09 further underscores the stock's volatility.
What are the main risks for GFOO?
The main risks for Genufood Energy Enzymes Corp. stem from its status as a shell company with no active business operations. These risks include the potential failure to find a suitable merger or acquisition target, the inability to raise capital to fund new ventures, and the possibility of delisting from the OTC market. The stock is highly speculative and subject to significant volatility. Investors should be aware of the limited liquidity and potential for fraud or manipulation in the OTC market. Thorough due diligence and risk management are essential before investing in GFOO.
What are the key factors to evaluate for GFOO?
Genufood Energy Enzymes Corp. (GFOO) currently holds an AI score of 44/100, indicating low score. Key strength: Existing corporate structure. Primary risk to monitor: Potential: Failure to find a suitable merger or acquisition target.. This is not financial advice.
How frequently does GFOO data refresh on this page?
GFOO prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GFOO's recent stock price performance?
Recent price movement in Genufood Energy Enzymes Corp. (GFOO) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Existing corporate structure. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GFOO overvalued or undervalued right now?
Determining whether Genufood Energy Enzymes Corp. (GFOO) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GFOO?
Before investing in Genufood Energy Enzymes Corp. (GFOO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be limited due to the company's status as a shell corporation.
- The analysis is subject to change based on new information or events.